Zyclara FDA Approval History
FDA Approved: Yes (First approved March 25, 2010)
Brand name: Zyclara
Generic name: imiquimod
Dosage form: Cream
Company: Graceway Pharmaceuticals, LLC
Treatment for: Keratosis, Condylomata Acuminata
Zyclara (imiquimod) is an immune response modifier indicated for the topical treatment of actinic keratoses and external genital warts.
Development timeline for Zyclara
| Date | Article |
|---|---|
| Jul 29, 2011 | Approval FDA Approves Zyclara (imiquimod) Cream, 2.5% for the Treatment of Actinic Keratoses |
| Mar 25, 2011 | Approval FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts |
| Mar 29, 2010 | Approval FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
